Biopharmaceuticals are temperature-critical: too hot or too cold ruins them, and vaccines and biologics increasingly had to fly across continents. Passive insulation and dry ice could not reliably hold a stable temperature across a multi-leg flight.

Envirotainer, founded in Stockholm in 1985, developed and marketed the first container with an active temperature-control system in 1995 — the container itself heats or cools to keep cargo at a set temperature for the whole journey.

The model was containers as a service: Envirotainer leases its fleet, runs more than 60 service stations worldwide and monitors shipments, so pharma customers get reliability without owning equipment. Today the fleet supports about 2 million doses of medicine a day.

Give the air container its own active temperature control

Active control holds a set temperature whatever the outside conditions.

Leasing spreads cost and lets pharma scale without capital.

A service-station network keeps equipment working wherever cargo flies.

Monitoring turns the cold chain from a gamble into documented evidence.

When the environment can't be trusted, don't just insulate against it — carry the environment with the product; a controlled microclimate turns an unreliable network into a dependable one.

Envirotainer became the pharma air-freight standard for active containers; EQT and Mubadala bought it in 2022 at a €2.8 billion enterprise value, and the fleet has grown beyond 6,000 containers.

FOLLOW THE EVIDENCE

The sources

  1. PE firms EQT and Mubadala buy Envirotainer for €2.8bn The Loadstar · theloadstar.com ·
  2. Envirotainer — Portfolio Cinven · cinven.com ·